Artificial neural network-based exploration of gene-nutrient interactions in folate and xenobiotic metabolic pathways that modulate susceptibility to breast cancer

被引:13
作者
Naushad, Shaik Mohammad [1 ]
Ramaiah, M. Janald [1 ]
Pavithrakumari, Manickam [1 ]
Jayapriya, Jaganathan [1 ]
Hussain, Tajamul [2 ]
Alrokayan, Salman A. [3 ]
Gottumukkala, Suryanarayana Raju [4 ]
Digumarti, Raghunadharao [5 ]
Kutala, Vijay Kumar [6 ]
机构
[1] SASTRA Univ, Sch Chem & Biotechnol, Tirumalaisamudram 613401, Thanjavur, India
[2] King Saud Univ, Ctr Excellence Biotechnol Res, POB 2455, Riyadh 11451, Saudi Arabia
[3] King Saud Univ, Dept Biochem, Coll Sci, POB 2455, Riyadh 11451, Saudi Arabia
[4] Nizams Inst Med Sci, Dept Surg Oncol, Hyderabad 500082, Andhra Pradesh, India
[5] Nizams Inst Med Sci, Dept Med Oncol, Hyderabad 500082, Andhra Pradesh, India
[6] Nizams Inst Med Sci, Dept Clin Pharmacol & Therapeut, Hyderabad 500082, Andhra Pradesh, India
关键词
Breast cancer; Folate pathway; Xenobiotic pathway; Artificial neural network; Methylome; ONE-CARBON METABOLISM; OXIDATIVE DNA-DAMAGE; POLYCHLORINATED-BIPHENYLS; CYTOCHROME-P450; 1A1; AFRICAN-AMERICAN; FOLIC-ACID; POLYMORPHISMS; RISK; ASSOCIATION; EXPRESSION;
D O I
10.1016/j.gene.2016.01.023
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
In the current study, an artificial neural network (ANN)-based breast cancer prediction model was developed from the data of folate and xenobiotic pathway genetic polymorphisms along with the nutritional and demographic variables to investigate how micronutrients modulate susceptibility to breast cancer. The developed ANN model explained 94.2% variability in breast cancer prediction. Fixed effect models of folate (400 mu g/day) and B-12 (6 mu g/day) showed 33.3% and 11.3% risk reduction, respectively. Multifactor dimensionality reduction analysis showed the following interactions in responders to folate: RFC1 G80A x MTHFR C677T (primary), COMT H108L x CYP1A1 m2 (secondary), MTR A2756G (tertiary). The interactions among responders to B-12 were RFC1G80A x cSHMT C1420T and CYP1A1 m2 x CYP1A1 m4. ANN simulations revealed that increased folate might restore ER and PR expression and reduce the promoter CpG island methylation of extra cellular superoxide dismutase and BRCA1. Dietary intake of folate appears to confer protection against breast cancer through its modulating effects on ER and PR expression and methylation of EC-SOD and BRCA1. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:159 / 168
页数:10
相关论文
共 46 条
  • [1] [Anonymous], 2006, USDA NAT NUTR DAT ST
  • [2] [Anonymous], 1989, NUTR VALUE INDIAN FO
  • [3] Micronutrients Involved in One-Carbon Metabolism and Risk of Breast Cancer Subtypes
    Cancarini, Ilaria
    Krogh, Vittorio
    Agnoli, Claudia
    Grioni, Sara
    Matullo, Giuseppe
    Pala, Valeria
    Pedraglio, Samuele
    Contiero, Paolo
    Riva, Cristina
    Muti, Paola
    Sieri, Sabina
    [J]. PLOS ONE, 2015, 10 (09):
  • [4] Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer
    Cavalieri, Ercole L.
    Rogan, Eleanor G.
    [J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2011, 125 (3-5) : 169 - 180
  • [5] Resveratrol inhibits TCDD-induced expression of CYP1A1 and CYP1B1 and catechol estrogen-mediated oxidative DNA damage in cultured human mammary epithelial cells
    Chen, ZH
    Hurh, YJ
    Na, HK
    Kim, JH
    Chun, YJ
    Kim, DH
    Kang, KS
    Cho, MH
    Surh, YJ
    [J]. CARCINOGENESIS, 2004, 25 (10) : 2005 - 2013
  • [6] Breast Cancer DNA Methylation Profiles Are Associated with Tumor Size and Alcohol and Folate Intake
    Christensen, Brock C.
    Kelsey, Karl T.
    Zheng, Shichun
    Houseman, E. Andres
    Marsit, Carmen J.
    Wrensch, Margaret R.
    Wiemels, Joseph L.
    Nelson, Heather H.
    Karagas, Margaret R.
    Kushi, Lawrence H.
    Kwan, Marilyn L.
    Wiencke, John K.
    [J]. PLOS GENETICS, 2010, 6 (07): : 1 - 10
  • [7] Dawling S, 2003, CANCER RES, V63, P3127
  • [8] Dietary Folate Intake and Breast Cancer Risk: European Prospective Investigation Into Cancer and Nutrition
    de Batlle, J.
    Ferrari, P.
    Chajes, V.
    Park, J. Y.
    Slimani, N.
    McKenzie, F.
    Overvad, K.
    Roswall, N.
    Tjonneland, A.
    Boutron-Ruault, M. C.
    Clavel-Chapelon, F.
    Fagherazzi, G.
    Katzke, V.
    Kaaks, R.
    Bergmann, M. M.
    Trichopoulou, A.
    Lagiou, P.
    Trichopoulos, D.
    Palli, D.
    Sieri, S.
    Panico, S.
    Tumino, R.
    Vineis, P.
    Bueno-de-Mesquita, H. B.
    Peeters, P. H.
    Hjartaker, A.
    Engeset, D.
    Weiderpass, E.
    Sanchez, S.
    Travier, N.
    Sanchez, M. J.
    Amiano, P.
    Chirlaque, M. D.
    Barricarte Gurrea, A.
    Khaw, K. T.
    Key, T. J.
    Bradbury, K. E.
    Ericson, U.
    Sonestedt, E.
    Van Guelpen, B.
    Schneede, J.
    Riboli, E.
    Romieu, I.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (01):
  • [9] Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation
    Goodman, JE
    Jensen, LT
    He, P
    Yager, JD
    [J]. PHARMACOGENETICS, 2002, 12 (07): : 517 - 528
  • [10] Hachey DL, 2003, CANCER RES, V63, P8492